Comparative Study between the Effects of Dexmedetomidine and Lidocaine Infusion on Intraoperative Hemodynamic and Requirement of Nalbuphine for Postoperative Analgesia in Upper Limb Orthopaedic Surgeries

Authors

  • Komal Mumtaz Author
  • Liaqat Ali Author
  • Saima Zia Author
  • Ramisha Afzal Author
  • Soman Nadim Iqbal Author
  • Malaika Nasir Author

DOI:

https://doi.org/10.51985/JBUMDC2025758

Keywords:

Dexmedetomidine, Heart rate, Lidocaine, Mean Arterial Pressure, Numeric rating scale

Abstract

 Objectives: To compare the intraoperative and postoperative hemodynamics and requirement of nalbuphine for postoperative
analgesia in upper limb orthopedic surgeries between dexmedetomidine and lidocaine.
Study Design: Comparative analytical study
Place and duration of study: Department of Anesthesia, Fauji Foundation Hospital, Rawalpindi, Pakistan from 17th Oct
22 to 15th July 23.
Methodology: Patients undergoing upper limb orthopedic surgeries in our tertiary care setup. Ninety patients undergoing
upper limb orthopaedic surgeries were divided into two equal groups of forty-five patients each. Group A received
Dexmedetomidine infusion, while Group B received Lidocaine infusion. Data collection involved gathering information
related to upper limb orthopaedic procedures, including both intraoperative and postoperative parameters.
Results: Ninety patients undergoing upper limb surgeries were randomized into two groups (Dexmedetomidine: Group
A, Lidocaine: Group B). Group A experienced statistically significant reductions in intraoperative mean arterial pressure
(MAP) by 20% (p<0.05) and heart rate (HR) by 15% (p<0.01) compared to Group B at all time points (10-120 minutes).
Postoperative pain scores were significantly higher in Group B (mean difference: 1.5 points, p<0.001) across all time points
(2-24 hours). Group A also exhibited significantly higher sedation scores (mean difference: 2 points, p<0.001) and required
significantly less postoperative analgesia (one dose vs. multiple doses, p<0.001) than Group B.
Conclusion: The findings affirm dexmedetomidine infusion's advantages in achieving optimal outcomes: improved
hemodynamics, reduced pain, and lowered postoperative analgesic demands, reinforcing its role in effective pain management. 

References

1. Ghosal, A., Debnath, T., Chakraborty, S., Das, D., Laha, A.,

Mandal, M., & Acharjee, A. (2024). Comparative study

between the effect of dexmedetomidine and lidocaine infusion

on intraoperative analgesic requirement and hemodynamics

during craniotomy. Asian Journal of Medical Sciences, 15(1),

19–26. https://doi.org/10.71152/ajms.v15i1.3373

2. Xu S, Wang S, Hu S, Ju X, Li Q, Li Y. Effects of lidocaine,

dexmedetomidine, and their combination infusion on

postoperative nausea and vomiting following laparoscopic

hysterectomy: a randomized controlled trial. BMC Anesthesiol.

2021 Dec 1;21(1). https://doi: 10.1186/s12871-021-01420-8.

3. Lee S. Dexmedetomidine: Present and future directions.

Korean J Anesthesiol. 2019 Aug 1;72(4):323–30. https:// doi:

10.4097/kja.19259

4. Beloeil H, Garot M, Lebuffe G, Gerbaud A, Bila J, Cuvillon

P, et al. Balanced Opioid-free Anesthesia with

Dexmedetomidine versus Balanced Anesthesia with

Remifentanil for Major or Intermediate Noncardiac Surgery:

The Postoperative and Opioid-free Anesthesia (POFA)

Randomized Clinical Trial. Anesthesiology. 2021 Apr

1;134(4):541–51. https:// doi: 10.1097/ALN.000000000000

3725.

5. Dere K, Sucullu I, Budak ET, Yeyen S, Filiz AI, Ozkan S,

Dagli G (July 2010). "A comparison of dexmedetomidine

versus midazolam for sedation, pain and hemodynamic control,

during colonoscopy under conscious sedation". European

Journal of Anaesthesiology. 27 (7): 648–652. doi:10.1097/

EJA.0b013e3283347bfe. PMID 20531094. S2CID 24778669.

6. Paris A, Tonner PH (August 2005). "Dexmedetomidine in

anaesthesia". Current Opinion in Anesthesiology. 18 (4):

412–418. doi:10.1097/01.aco.0000174958.05383.d5. PMID

16534267. S2CID 20014479.

7. Giovannitti JA, Thoms SM, Crawford JJ (2015-01-01). "Alpha-

2 adrenergic receptor agonists: a review of current clinical

applications". Anesthesia Progress. 62 (1): 31–39. doi:10.2344/

0003-3006-62.1.31. PMC 4389556. PMID 25849473.

8. Ahmed SS, Unland T, Slaven JE, Nitu ME, Rigby MR

(September 2014). "Successful use of intravenous

dexmedetomidine for magnetic resonance imaging sedation

in autistic children". Southern Medical Journal. 107 (9):

559–564. doi:10.14423/SMJ.0000000000000160. PMID

25188619. S2CID 43652106.

9. Foo I, Macfarlane AJR, Srivastava D, Bhaskar A, Barker H,

Knaggs R, et al. The use of intravenous lidocaine for

postoperative pain and recovery: international consensus

statement on efficacy and safety. Anaesthesia. 2021 Feb

1;76(2):238–50. https://DOI: 10.1111/anae.15270

10. Bugada D, Bellini V, Fanelli A, Marchesini M, Compagnone

C, Baciarello M, et al. Future Perspectives of ERAS: A

Narrative Review on the New Applications of an Established

Approach. Surg Res Pract. 016;2016:1–6. https://DOI:

10.1155/2016/3561249

11. Yu P, Zhang J, Zou Y, Wang J. Effect of Preventive Analgesia

with Nalbuphine and Dexmedetomidine in Endoscopic Sinus

Surgery. Pain Res Manag. 2022;2022. https://doi:10.1155

/2022/ 2344733

12. Tompkins DA, Campbell CM. Opioid-induced hyperalgesia:

Clinically relevant or extraneous research phenomenon? Vol.

15, Current Pain and Headache Reports. 2011. p. 129–36.

https://doi: 10.1007/s11916-010-0171-1.

13. Minkowitz HS, Scranton R, Gruschkus SK, Nipper-Johnson

K, Menditto L, Dandappanavar A. Development and Validation

of a Risk Score to Identify Patients at High Risk for OpioidRelated Adverse Drug Events [Internet]. Vol. 20, Journal of

Managed Care & Specialty Pharmacy JMCP September. 2014.

Available from: www.amcp.org. https:// doi: 10.18553/jmcp.

2014.20.9.948.

14. Imani F, Zaman B, De Negri P. Postoperative pain management:

Role of dexmedetomidine as an adjuvant. Anesth Pain Med.

2020 Dec 1;10(6):1–2. https:// doi: 10.5812/aapm.112176

15. Chrysostomou C, Schmitt CG. Dexmedetomidine: sedation,

analgesia and beyond. Expert Opin Drug Metab Toxicol. 2008

May;4(5):619-27. doi: 10.1517/17425255.4.5.619. PMID:

18484919.

16. Mohammed NS, Habib MK, Abbas EA, Mahmoud SM,

Ramadan IA. Comparative study between the effect of

dexmedetomidine and lidocaine infusion in lumbar fixation

on hemodynamics, fentanyl requirements, and postoperative

analgesia. Ain-Shams Journal of Anesthesiology. 2020

Dec;12(1). https://doi.org/10.1186/s42077-020-00119-1

17. Nusrullah Khan, Ahmed Shakeel Ahsan Rizvi,Muhammad

Sarfraz Vol.18 NO 1 ,Comparison of Dexmedetomidine with

Midazolam during Monitored Care Anesthesia (MAC) in

Patients Undergoing SeptoplastyPak Armed Forces Med J.

2020 https://doi.org/10.48036/apims.v18i1.509

17. Hassan SU, Abbas N, Tariq S, Murtaza G, Iftekhar A, Moazzam

H. Comparative Study of Dexmedtomidine& Propofol Infusion

for Intro-Operative Hemodynamic & Recovery Characteristics

in Laparoscopic Cholecystectomy – A Prospective,

Randomized Control Study. Pakistan Journal of Medical and

Health Sciences. 2023 Jan 31;17(1):297–9. https://doi.org/

10.53350/pjmhs2023171297

18. Singh V, Pahade A, Mowar A. Comparing efficacy of

intravenous dexmedetomidine and lidocaine on perioperative

analgesic consumption in patients undergoing laparoscopic

surgery. Anesth Essays Res. 2022;16(3):353. https:// doi: 10.

4103/aer.aer_121_22.

19. Anis S, Samir G, ElSerwi H. Lidocaine versus

dexmedetomidine infusion in diagnostic laparoscopic

gynecologic surgery: a comparative study. Ain-Shams Journal

of Anaesthesiology. 2016;9(4):508. https://doi:

10.4103/aer.aer_121_22

20. Anandani DN, Kapdi MS, Patel AD, Jain P. Comparison of

Intravenous Lignocaine and Dexmedetomidine for Attenuation

of Hemodynamic Stress Response to Laryngoscopy and

Endotracheal Intubation. J Evol Med Dent Sci. 2021 Apr

19;10(16):1123–9. https:// DOI: 10.14260/jemds/2021/240

21. Hashemi M, Dadkhah P, Taheri M, Ghasemi M. Effects of

Caudal Epidural Dexmedetomidine on Pain, Erythrocyte

Sedimentation Rate and Quality of Life in Patients with Failed

Back Surgery Syndrome; A Randomized Clinical Trial. Bull

Emerg Trauma. 2019 Jul 1;7(3):245–50. 22. Tarýkçý Kýlýç

E, Aydýn G. Effects of dexmedetomidine infusion during

spinal anesthesia on hemodynamics and sedation. Libyan

Journal of Medicine. 2018 Jan 1;13(1). https:// doi: 10.1080/

19932820.2018.1436845

23. Gunjan, Kohli M, Singh PK, Gupta R, Chaudhary AK, Kumar

V, et al. Multimodal versus conventional approach for

postoperative pain relief in oral cancer patients. Journal of

Clinical and Diagnostic Research. 2016 Jan 1;10(1):UC05–8.

https://doi: 10.7860/JCDR/2016/13785.7027

24. Hetta DF, Fares KM, Abedalmohsen AM, Abdel-Wahab AH,

Elfadl GMA, Ali WN. Epidural dexmedetomidine infusion

for perioperative analgesia in patients undergoing abdominal

cancer surgery: Randomized trial. J Pain Res. 2018;11:

2675–85. https:// doi: 10.2147/JPR.S163975

25. Bugada D, Lorini LF, LavanD’Homme P. Opioid free

anesthesia: Evidence for short and long-term outcome. Vol.

87, Minerva Anestesiologica. Edizioni Minerva Medica; 2021.

p. 230–7. https://doi: 10.23736/S0375-9393.20.14515-2

Downloads

Published

2026-01-14

Issue

Section

Original Articles

Similar Articles

11-20 of 37

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)